| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
TPT-172 HCl (R33) targets protein targets through its thiourea moiety, which can form hydrogen bonds and coordinate with metal ions in enzyme active sites. It is a thiophene thiourea analog that may inhibit enzymes involved in oxidative stress or metal homeostasis. Its exact molecular target is not fully characterized, but its structure suggests potential activity against metalloenzymes and redox-related proteins.
|
|---|---|
| ln Vitro |
In vitro, TPT-172 HCl (R33) has been evaluated for its biological activity in various assays. Its thiophene thiourea structure suggests potential antioxidant, antimicrobial, or anticancer activities. It is used as a reference compound in studies of thiourea-based pharmacophores. Detailed in vitro potency data are limited in the public literature.
|
| ln Vivo |
In vivo, TPT-172 HCl (R33) has not been extensively characterized in animal models. Its thiophene thiourea structure suggests potential for oral bioavailability and tissue distribution. It is primarily used as a research tool rather than a therapeutic candidate, and its in vivo efficacy and safety profiles are not well established.
|
| Enzyme Assay |
The in vitro enzyme/receptor binding assay for TPT-172 HCl (R33) would typically involve incubating the compound with purified target enzymes (e.g., metalloenzymes, oxidoreductases) and measuring inhibition of enzymatic activity using colorimetric or fluorometric substrates. IC50 values would be determined from dose-response curves.
|
| Cell Assay |
In vitro cell experiments with TPT-172 HCl (R33) use cancer or microbial cell lines. Cells are treated with the compound, and cell viability is measured by MTT assay. Its effects on oxidative stress markers (e.g., ROS, glutathione) and enzyme activities are assessed by biochemical assays and Western blotting.
|
| Animal Protocol |
In vivo animal experiments with TPT-172 HCl (R33) would involve administering the compound to rodents to assess pharmacokinetics, toxicity, and efficacy in disease models. Tumor growth inhibition or antimicrobial efficacy would be measured, and tissue distribution would be determined by LC-MS/MS.
|
| Molecular Formula |
C6H9CLN2S2
|
|---|---|
| Molecular Weight |
208.7321
|
| Exact Mass |
207.99
|
| CAS # |
32415-42-2
|
| Related CAS # |
109841-87-4;32415-42-2 (HCl);
|
| PubChem CID |
13257203
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.4g/cm3
|
| Boiling Point |
289.5ºC at 760 mmHg
|
| Flash Point |
128.9ºC
|
| Index of Refraction |
1.691
|
| LogP |
3.476
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
11
|
| Complexity |
127
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
GFYZVDOORWWFNZ-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C6H8N2S2.ClH/c7-6(8)10-4-5-2-1-3-9-5;/h1-3H,4H2,(H3,7,8);1H
|
| Chemical Name |
thiophen-2-ylmethyl carbamimidothioate;hydrochloride
|
| Synonyms |
TPT 172 TPT-172 TPT172
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.7909 mL | 23.9544 mL | 47.9088 mL | |
| 5 mM | 0.9582 mL | 4.7909 mL | 9.5818 mL | |
| 10 mM | 0.4791 mL | 2.3954 mL | 4.7909 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
